Expert Consensus on the Clinical Use of Skin Boosters: A Delphi-Based Recommendation Framework
NCT ID: NCT07296601
Last Updated: 2025-12-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
15 participants
OBSERVATIONAL
2025-12-25
2027-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The project seeks to establish practical, consensus-driven guidelines that can harmonize clinical practice, enhance treatment outcomes, and ensure patient safety. The final recommendations will serve as a reference framework for practitioners and contribute to the standardization of skin quality enhancement treatments.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This research project aims to develop comprehensive, evidence-informed consensus guidelines for the use of skin boosters in aesthetic practice. The study will use a structured Delphi methodology to gather and synthesize the perspectives of leading dermatologists and aesthetic medicine specialists. Through multiple iterative rounds, experts will evaluate and rate a series of statements addressing key clinical domains including: appropriate indications; patient selection criteria; anatomical considerations; recommended injection depths and techniques; dosing strategies; frequency and number of treatment sessions; choice of products (e.g., HA-based, polynucleotides, bio-remodeling agents); combination therapies; expected outcomes; management of adverse events; and contraindications.
The consensus-building process ensures anonymity, reduces bias, and encourages equal participation among experts. Quantitative analyses (e.g., percentage agreement thresholds, median and interquartile range scoring) will be used to determine which statements achieve consensus. Statements not reaching agreement will be revised and re-evaluated in subsequent rounds until final consensus is achieved.
By the end of the project, the expert panel will produce clear, standardized, and clinically actionable recommendations that can be used globally or regionally to harmonize the use of skin boosters. These guidelines will support clinicians by improving the consistency and quality of care, informing training programs, guiding patient counseling, and reducing complication rates. Ultimately, the project aims to fill a critical gap in aesthetic dermatology literature by establishing a scientifically grounded, consensus-driven framework for safe and effective skin booster therapy
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Expert Panel
A cohort of dermatology and aesthetic medicine experts participating in a Modified Delphi process to develop consensus recommendations on skin booster use.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Board-certified dermatologist or aesthetic physician
With recognized qualification in dermatology, aesthetic medicine, plastic surgery, or related fields.
Minimum clinical experience
At least 5 years of experience performing aesthetic injectable procedures.
OR at least 3 years of consistent use of skin boosters in clinical practice.
Demonstrated expertise in skin booster therapy
Must have performed ≥100 skin booster procedures overall,
OR ≥20 sessions per year over the past 2 years.
Active clinical practice
Currently practicing in an aesthetic or dermatology clinic, medical center, or hospital.
Authorship or contribution to aesthetic/dermatology education (desirable but not mandatory)
Publications, lectures, workshop instruction, or conference involvement in aesthetics.
Ability to participate in Delphi rounds
Must agree to complete all survey rounds within the specified timeframe.
Must be fluent in the language used for the study (e.g., English or Arabic).
Willingness to provide informed consent
Voluntary participation with confidentiality maintained.
Exclusion Criteria
\<5 years of aesthetic practice
OR insufficient hands-on experience with skin booster injections.
Limited familiarity with skin booster products or techniques
No regular use in the last 2 years.
Has not performed the minimum number of required procedures.
Industry conflict of interest
Direct employment by a company manufacturing skin booster products.
Significant financial relationship with a single product manufacturer that may bias responses.
Inability to commit to multiple Delphi rounds
Anticipated non-compliance or non-response in iterative rounds.
Non-clinical or administrative professionals
Those not actively practicing (e.g., retired, research-only positions, students, trainees).
Participation in a competing guideline project
Experts currently serving on another skin booster consensus panel to avoid duplication or bias.
Failure to provide informed consent
Declines participation or withdraws consent at any time.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Venus Research Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Venus Research Center
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Skin Booster-VenusRC
Identifier Type: -
Identifier Source: org_study_id